Objective Glomerular immune complex deposition plays a central role in lupus nephritis (LN), but the prognostic relevance of individual immunoglobulin components remains unclear. This study aimed to ...

Objective SLE affects multiple organs and is associated with increased mortality and organ damage. While treatment ...

Introduction SLE is a chronic autoimmune disease characterised by multisystem involvement and fluctuating clinical course, ...

Objective Pregnant patients with systemic lupus erythematosus (SLE) have 2-3 times higher risk of preterm delivery (PTD).

Objective No studies have investigated the incidence and correlation of scarring and dyspigmentation across all cutaneous ...

Objective Negative self-perceptions of ageing are associated with decreased health-related quality of life (HRQoL) in older ...

22 Historical aspects of B-cell depletion in SLE (8 October, 2025) ...

*This non-accredited industry-sponsored symposium is not part of the accredited CME programme.

Fumaric acid esters in cutaneous lupus erythematosus Fumaric acid esters (FAEs), established immunomodulatory agents in the treatment of psoriasis and multiple sclerosis, have been investigated for ...

Belimumab (BEL) is a monoclonal antibody that selectively binds to BLyS, a survival factor for B cells, while anifrolumab (ANI) is a monoclonal antibody that binds to the type I interferon (IFN) ...

In 1998 Edwards and Cambridge from University College London became increasingly convinced that B-lymphocytes were critically involved in the development of rheumatoid arthritis. 1 For some people at ...

Lupus nephritis is a serious complication of systemic lupus erythematosus and a major driver of morbidity and mortality. Current clinical monitoring relies heavily on proteinuria and kidney ...